The MEK/ERK Pathway Acts Upstream of NFκB1 (p50) Homodimer Activity and Bcl-2 Expression in a Murine B-Cell Lymphoma Cell Line

This publication has 47 references indexed in Scilit:

• A Novel NF-κB-inducing Kinase-MAPK Signaling Pathway Up-regulates NF-κB Activity in Melanoma Cells
  Journal of Biological Chemistry, 2002
• Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
  Journal of Clinical Investigation, 2001
• Phosphorylation Meets Ubiquitination: The Control of NF-κB Activity
  Annual Review of Immunology, 2000
• Aberrant rel/nfkb genes and activity in human cancer
  Oncogene, 1999
• Activators and target genes of Rel/NF-κB transcription factors
  Oncogene, 1999
• The role of NF-κB/IκB proteins in cancer: implications for novel treatment strategies
  Surgical Oncology, 1999
• Differential regulation of IκB kinase α and β by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1
  Proceedings of the National Academy of Sciences, 1998
• Identification and Characterization of an IκB Kinase
  Cell, 1997
• Activation of the IκBα Kinase Complex by MEKK1, a Kinase of the JNK Pathway
  Cell, 1997
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
  Annual Review of Immunology, 1996